An overview of EBMT 2017 by Prof. Mohamad Mohty
The basis for immunotherapy in multiple myeloma
Ignacio Melero Bermejo
iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
Remission maintenance with histamine dihydrochloride (HDC)/IL-2 therapy in AML
Highlights from COMy and how to reset the immune system in multiple myeloma
Paul Richardson et al.